Market Tracker

10/24 6:05pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

5.00
Data as of Oct 24
 -0.08 / -1.57%
Today’s Change
4.91
Today|||52-Week Range
53.40
-54.95%
Year-to-Date
No recent news for EPIRUS Biopharmaceuticals Inc.

Today’s Trading

Previous close5.08
Today’s open5.10
Day’s range4.91 - 5.10
Volume15,153
Average volume (3 months)21,763
Market cap$64.6M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+26.32%
Earnings growth (this year)+93.93%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.38%
P/E ratio1.6
Price/Sales1.73
Price/Book0.92

Competitors

 Today’s
change
Today’s
% change
COCPCocrystal Pharma Inc+0.05+10.42%
ADXSAdvaxis Inc+0.25+8.12%
LPCNLipocine Inc-0.08-1.52%
MSTXMast Therapeutics In...-0.01-1.40%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)-$0.43
Annual revenue (last year)$14.7M
Annual profit (last year)-$38.6M
Net profit margin-262.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts